Skip to main content
TXG
NASDAQ Life Sciences

10x Genomics Lifts Full-Year Revenue Guidance After Q3 Beat, Atera Ramp Begins

Tom Rudovsky · Reported by PR Newswire
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$57.717
Mkt Cap
$7.565B
52W Low
$12.8
52W High
$102.81
52W Position info
351% above low
Off High info
44% below high
Rel. Volume info
1.7× avg
Market data snapshot near publication time

TXG has more than doubled off its 52-week low of $12.8.

Summary

10x Genomics raised full-year 2026 revenue guidance to $625M-$635M from $610M-$630M after Q3 revenue came in at $150.7M, up 1% year over year. Gross margin jumped to 75% from 67% on lower inventory write-downs and better product mix, and the net loss narrowed to $19.4M from $27.5M, with the quarterly loss per share at 15c. The quarter's real story is Atera: the next-generation spatial platform began global commercial shipments, following the September launch announcement, and management called early demand extraordinary. Consumables carried the top line — spatial consumables rose to $41.2M from $35.4M — while instrument revenue fell to $6.9M from $12.0M, a mix shift that supports margins. The company also introduced Sentira, a cloud analysis platform built on NVIDIA computing and Anthropic's Claude. Cash and marketable securities stood at $575.7M, giving ample runway against the current loss run rate.

At the time of this announcement, TXG was trading at $57.72 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $7.6B. The 52-week trading range was $12.80 to $102.81. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

TXG - Latest Insights

TXG
Nov 05, 2026, 5:35 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $57.61
Real-time Price: $61.20 info
Change: +$3.59 (+6%) info
Market Cap: $7.724B info
TXG
Sep 29, 2026, 9:00 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $89.46
Real-time Price: $61.20 info
Change: -$28.26 (-32%) info
Market Cap: $7.724B info
TXG
Aug 06, 2026, 5:31 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $43.07
Real-time Price: $61.20 info
Change: +$18.13 (+42%) info
Market Cap: $7.724B info
TXG
Jun 09, 2026, 9:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $29.50
Real-time Price: $61.20 info
Change: +$31.70 (+107%) info
Market Cap: $7.724B info
TXG
May 07, 2026, 5:36 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $21.46
Real-time Price: $61.20 info
Change: +$39.74 (+185%) info
Market Cap: $7.724B info